Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

v3.24.3
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Revenues:        
License and other revenues $ 3,500
Expenses:        
Royalties 30 1,605
Research and development 8,941 7,148 25,366 23,712
General and administrative 6,404 4,156 22,173 13,174
Gain on operating lease right-of-use assets (1,065)
Total expenses 15,345 11,334 47,539 37,426
Loss from operations (15,345) (11,334) (47,539) (33,926)
Interest income 1,189 593 3,223 1,374
Interest expense (1,102) (105) (3,126) (309)
Change in fair value of warrant and derivative liabilities (15,156) (1,101) (7,530) (7,465)
Other income 145 111 531 2,729
Net Loss $ (30,269) $ (11,836) $ (54,441) $ (37,597)
Basic loss per common share $ (0.63) $ (0.48) $ (1.41) $ (1.89)
Dilutive loss per common share $ (0.63) $ (0.48) $ (1.41) $ (1.89)
Weighted average number of common shares outstanding - basic 48,081,758 24,797,564 38,504,273 19,942,613
Weighted average number of common shares outstanding - diluted 48,081,758 24,797,564 38,504,273 19,942,613
Other comprehensive income (loss):        
Change in unrealized gains (losses) related to available-for-sale debt securities $ 50 $ (33) $ (18) $ 1
Foreign currency translation adjustments 29 29
Comprehensive loss $ (30,219) $ (11,840) $ (54,459) $ (37,567)